Komorowski J - Search Results

1

Chromium supplementation does not improve glucose tolerance, insulin sensitivity, or lipid profile: a randomized, placebo-controlled, double-blind trial of supplementation in subjects with impaired glucose tolerance: response to Gunton et al.

Komorowski J, Juturu V. Komorowski J, et al. Diabetes Care. 2005 Jul;28(7):1841-2; author reply 1842-3. doi: 10.2337/diacare.28.7.1841-a. Diabetes Care. 2005. PMID: 15983360 No abstract available.

2

Chromium supplements, glucose, and insulin responses.

Juturu V, Komorowski JR. Juturu V, et al. Am J Clin Nutr. 2003 Jul;78(1):190; author reply 192-3. doi: 10.1093/ajcn/78.1.190. Am J Clin Nutr. 2003. PMID: 12816790 No abstract available.

3

Chromium compounds: cytotoxicity and carcinogenesis.

Juturu V, Komorowski JR. Juturu V, et al. Toxicology. 2003 Apr 15;186(1-2):171-3; author reply 175-7. doi: 10.1016/s0300-483x(02)00707-2. Toxicology. 2003. PMID: 12604181 No abstract available.

4

Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial.

Geohas J, Daly A, Juturu V, Finch M, Komorowski JR. Geohas J, et al. Among authors: komorowski jr. Am J Med Sci. 2007 Mar;333(3):145-53. doi: 10.1097/MAJ.0b013e318031b3c9. Am J Med Sci. 2007. PMID: 17496732 Clinical Trial.

5

Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial.

Albarracin C, Fuqua B, Geohas J, Juturu V, Finch MR, Komorowski JR. Albarracin C, et al. Among authors: komorowski jr. J Cardiometab Syndr. 2007 Spring;2(2):91-7. doi: 10.1111/j.1559-4564.2007.06366.x. J Cardiometab Syndr. 2007. PMID: 17684468 Clinical Trial.

6

Chromium picolinate modulates serotonergic properties and carbohydrate metabolism in a rat model of diabetes.

Komorowski JR, Tuzcu M, Sahin N, Juturu V, Orhan C, Ulas M, Sahin K. Komorowski JR, et al. Biol Trace Elem Res. 2012 Oct;149(1):50-6. doi: 10.1007/s12011-012-9393-x. Epub 2012 Mar 22. Biol Trace Elem Res. 2012. PMID: 22434381

7

Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin.

Sahin K, Tuzcu M, Orhan C, Sahin N, Kucuk O, Ozercan IH, Juturu V, Komorowski JR. Sahin K, et al. Br J Nutr. 2013 Jul 28;110(2):197-205. doi: 10.1017/S0007114512004850. Epub 2012 Dec 5. Br J Nutr. 2013. PMID: 23211098

8

The effects of chromium histidinate on mineral status of serum and tissue in fat-fed and streptozotocin-treated type II diabetic rats.

Dogukan A, Sahin N, Tuzcu M, Juturu V, Orhan C, Onderci M, Komorowski J, Sahin K. Dogukan A, et al. Among authors: komorowski j. Biol Trace Elem Res. 2009 Nov;131(2):124-32. doi: 10.1007/s12011-009-8351-8. Epub 2009 Mar 7. Biol Trace Elem Res. 2009. PMID: 19271160

9

Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.

Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR. Sahin K, et al. Metabolism. 2007 Sep;56(9):1233-40. doi: 10.1016/j.metabol.2007.04.021. Metabolism. 2007. PMID: 17697867

10

Chromium picolinate does not produce chromosome damage.

Komorowski JR, Greenberg D, Juturu V. Komorowski JR, et al. Toxicol In Vitro. 2008 Apr;22(3):819-26. doi: 10.1016/j.tiv.2007.12.007. Epub 2007 Dec 25. Toxicol In Vitro. 2008. PMID: 18261879

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

310 results

Search Page